Literature DB >> 25670474

Effects of toluidine blue O (TBO)-photodynamic inactivation on community-associated methicillin-resistant Staphylococcus aureus isolates.

Sung-Pin Tseng1, Wei-Chun Hung2, Hsiao-Jan Chen3, Yu-Tzu Lin3, Hung-Sih Jiang3, Hao-Chieh Chiu3, Po-Ren Hsueh4, Lee-Jene Teng5, Jui-Chang Tsai6.   

Abstract

BACKGROUND/
OBJECTIVES: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) was recognized as a leading pathogen and has been shown to be genetically different from the health care-associated MRSA (HA-MRSA). Photodynamic therapy (PDT) is considered a potential alternative method for the treatment of resistant bacterial infections, but the effect of PDT on CA-MRSA is unknown. The purpose of this study was to compare the bactericidal effects of toluidine blue O (TBO) on CA-MRSA and HA-MRSA and investigate the photodynamic inactivation effects of TBO (TBO-PDI) against bacterial virulence factors.
MATERIALS AND METHODS: TBO-PDI effects were determined by measuring the survival fractions for four strains and bactericidal activities for 26 CA-MRSA isolates and 26 HA-MRSA isolates. The influences of TBO-PDI on DNA fragmentation and the activities of protease, lipase, staphylococcal α-hemolysin, and enterotoxin were studied.
RESULTS: TBO-PDI has effective bactericidal activity against both CA- and HA-MRSA. However, the bactericidal activity of TBO-PDI was significantly higher against HA-MRSA than CA-MRSA isolates. In addition, TBO-PDI treatment using a sublethal TBO concentration led to reduced production of several virulence factors, including protease, lipase, staphylococcal α-hemolysin, and enterotoxin.
CONCLUSION: Although TBO-PDI is slightly less effective against CA-MRSA than HA-MRSA isolates, TBO-PDI could reduce the production of virulence factors at a sublethal TBO concentration, which would be beneficial for treating CA-MRSA infections.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  CA-MRSA; photodynamic inactivation; virulence factors

Mesh:

Substances:

Year:  2015        PMID: 25670474     DOI: 10.1016/j.jmii.2014.12.007

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  4 in total

Review 1.  New photosensitizers for photodynamic therapy.

Authors:  Heidi Abrahamse; Michael R Hamblin
Journal:  Biochem J       Date:  2016-02-15       Impact factor: 3.857

2.  In vitro and in vivo photodynamic efficacies of novel and conventional phenothiazinium photosensitizers against multidrug-resistant Candida auris.

Authors:  Patrícia Helena Grizante Barião; Ludmilla Tonani; Guilherme Thomaz Pereira Brancini; Erika Nascimento; Gilberto Úbida Leite Braga; Mark Wainwright; Marcia Regina von Zeska Kress
Journal:  Photochem Photobiol Sci       Date:  2022-07-11       Impact factor: 4.328

3.  Synergistic photoactivated antimicrobial effects of carbon dots combined with dye photosensitizers.

Authors:  Xiuli Dong; Ambrose E Bond; Nengyu Pan; Montrez Coleman; Yongan Tang; Ya-Ping Sun; Liju Yang
Journal:  Int J Nanomedicine       Date:  2018-11-27

4.  Validation of stable reference genes in Staphylococcus aureus to study gene expression under photodynamic treatment: a case study of SEB virulence factor analysis.

Authors:  Patrycja Ogonowska; Joanna Nakonieczna
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.